PIR® is designed to assist physicians in helping their patients to reduce insulin resistance.
Multi-patented
Multi-patented protocol for metabolic disorder, protected by issued U.S. patents and pending applications.
Component Regulatory Status
PIR®'s method of delivery is the subject of a De Novo submission pathway with FDA and has not been cleared or approved.
Insulin: FDA-approved biologic
Infusion pump: FDA-cleared device
Domestic & international
Physicians, clinics, health institutions, professionals, and academia based affiliates. We’d love for your organization to become our next.
What We Provide
PIR®, Physiologic Insulin Resensitization®, Physician-Directed Physiologic Insulin Resensitization®, and Insulin Used as a Hormone Rather Than a Drug®. These trademarks serve as source identifiers for our solutions and services.
Addressing insulin resistance
Medical tools designed to address insulin resistance and support improved metabolic health.
PIR® Products & Training
Educational programs for licensees and their health care providers to help them deliver PIR® under physician direction to diabetic and insulin-resistant patients in their own practices.
welcome to well cell
Want to Explore PIR®?
Please fill out the form below with your contact information. We’ll get back to you as soon as possible!
Developing Leaders for a Connected World
We work with global partners to prepare ethical, capable leaders for today’s interconnected challenges.
Through global partnerships and hands-on learning, we develop ethical, globally minded leaders prepared to address today’s most pressing challenges. Our programs connect participants across countries and cultures, blending leadership development with real-world impact, cross-cultural collaboration, and professional growth.